All Information (Except Text) for S.2956 - Patients First Act of 2018115th Congress (2017-2018)
|Sponsor:||Sen. Wicker, Roger F. [R-MS] (Introduced 05/24/2018)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 05/24/2018 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
There is 1 version of this bill. View text
Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries
Actions Overview (1)
|05/24/2018||Introduced in Senate|
05/24/2018 Introduced in Senate
All Actions (1)
|05/24/2018||Read twice and referred to the Committee on Health, Education, Labor, and Pensions.|
Action By: Senate
05/24/2018 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|Sen. Daines, Steve [R-MT]*||05/24/2018|
|Sen. Blunt, Roy [R-MO]*||05/24/2018|
|Sen. Lankford, James [R-OK]*||05/24/2018|
|Sen. Inhofe, James M. [R-OK]||06/11/2018|
|Sen. Hyde-Smith, Cindy [R-MS]||07/31/2018|
|Committee / Subcommittee||Date||Activity||Related Documents|
|Senate Health, Education, Labor, and Pensions||05/24/2018||Referred to|
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
Latest Summary (1)
Introduced in Senate (05/24/2018)
Patients First Act of 2018
This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that the techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill.
HHS must issue guidelines to ensure that any research (including any clinical trial) supported under this bill: (1) is clearly consistent with the standards established in this bill, if conducted using human cells; and (2) is prioritized in terms of potential for near-term clinical benefit in human patients.
HHS must report on peer reviewed stem cell research proposals that were not funded.